B2DB — Who said what, where, and when

Simon Bornschein

CEO, Coding Bio

Coding Bio builds complex multispecific T-cell engagers with OR-gate logic to block tumour escape. Their lead programme CB-101 will enter the clinic in Q1 2027.

Events Simon Bornschein has spoken at